CODX News and Press, Co-Diagnostics Inc.

Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 PR Newswire SALT LAKE CITY , June 18, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented plat...

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform PR Newswire The Company expects that the application for OTC clearance will shortly be followed by pursuit of POC clearance, with other tests in the pipeline to meet the needs of a global ma...

A look at the top 10 most actives in the United States Freight Technologies Inc. (FRGT) rose 10.4% to $0.6899 on volume of 220,478,071 shares Nauticus Robotics Inc. (KITT) rose 23.2% to $0.17 on volume of 217,326,595 shares GameStop Corporation (GME) rose 47.5% to $46.55 on volume of 178,...

2024-05-09 21:30:12 ET Co-Diagnostics, Inc. (CODX) Q1 2024 Earnings Conference Call May 09, 2024, 04:30 PM ET Company Participants Andrew Benson - Head, Investor Relations Dwight Egan - Chief Executive Officer Brian Brown - Chief Financial Officer Conferenc...

2024-05-09 16:05:10 ET More on Co-Diagnostics Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Co-Diagnostics Historical earnings data for Co-Diagnostics Financial information for Co-Diagnostics Rea...

Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results PR Newswire SALT LAKE CITY , May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the de...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

2024-05-08 17:20:21 ET More on Co-Diagnostics Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Co-Diagnostics Historical earnings data for Co-Diagnostics Financial information for Co-Diagnostics Rea...

Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...